Nervgen Pharma Corp

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.05

-0.22 (-9.69%)

As of Sep 20, 10:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +509.3% upside

Low Target $8.17

Average Target $12.49

High Target $18.41

Current Price $2.05

Current
$2.05

Target
$12.49

$8.17 $12.49 avg $18.41

Scenario Analysis

Bear Case

$8.17

298.5%

Low target

Base Case

$12.49

+509.3%

Avg target

Bull Case

$18.41

+798.0%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$8.49

-75.9% from high

52-Week Low

$3.20

+-35.9% from low

Target vs 52W High

$12.49

+47.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%